These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7190531)

  • 1. Treatment of advanced endometrial adenocarcinoma with cis-dichlorodiammine platinum (II) after intensive prior therapy.
    Deppe G; Cohen CJ; Bruckner HW
    Gynecol Oncol; 1980 Aug; 10(1):51-4. PubMed ID: 7190531
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of advanced endometrial carcinoma with cisplatin, cyclophosphamide and doxorubicin.
    Deppe G; Lin Liu T
    Acta Obstet Gynecol Scand; 1985; 64(1):83-4. PubMed ID: 4038840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [cis-Dichlorodiammine platinum (II) in the treatment of advanced colo-rectal cancer].
    Dozono H; Moriya Y; Saijo N; Fujita J; Koyama Y
    Gan To Kagaku Ryoho; 1985 Jul; 12(7):1465-9. PubMed ID: 2990351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of advanced or recurrent endometrial adenocarcinoma with cyclophosphamide, doxorubicin, cis-Platinum, and megestrol acetate.
    Lovecchio JL; Averette HE; Lichtinger M; Townsend PA; Girtanner RW; Fenton AN
    Obstet Gynecol; 1984 Apr; 63(4):557-60. PubMed ID: 6538327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of recurrent endometrial adenocarcinoma with a combination of doxorubicin and cisplatin.
    Tropé C; Johnsson JE; Simonsen E; Christiansen H; Cavallin-Ståhl E; Horváth G
    Am J Obstet Gynecol; 1984 Jun; 149(4):379-81. PubMed ID: 6539567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of gynecological cancer with cis-platinum].
    Mano T; Takeshima N; Nakamura Y; Tomimatsu T; Saito T; Miyake T
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2895-9. PubMed ID: 3662545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Phase II study of cisplatin in cervical and endometrial carcinomas].
    Noda K; Takeuchi S; Kurihara S; Sugawa T; Kato T; Ikeda M; Kanazawa K; Tsutsui F; Yamamoto K; Umezu J
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1129-35. PubMed ID: 3566307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adriamycin and cis-diamminedichloroplatinum in the treatment of metastatic endometrial adenocarcinoma.
    Seltzer V; Vogl SE; Kaplan BH
    Gynecol Oncol; 1984 Nov; 19(3):308-13. PubMed ID: 6542050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis as a criterion for sensitivity of uterine cervical adenocarcinoma to cisplatin.
    Sekiguchi I; Suzuki M; Ohwada M; Sato I
    Oncol Rep; 1998; 5(5):1077-8. PubMed ID: 9683811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II study of Cis-platinum for recurrent corpus cancer.
    Tropé C; Grundsell H; Johnsson JE; Cavallin-Ståhl E
    Eur J Cancer (1965); 1980 Aug; 16(8):1025-6. PubMed ID: 7192215
    [No Abstract]   [Full Text] [Related]  

  • 11. Potentiation of radiotherapy by cis-dichlorodiammine platinum (II) in advanced cervical carcinoma.
    Choo YC; Choy TK; Wong LC; Ma HK
    Gynecol Oncol; 1986 Jan; 23(1):94-100. PubMed ID: 3510946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II evaluation of dianhydrogalactitol in the treatment of advanced endometrial adenocarcinoma: a Gynecologic Oncology Group Study.
    Stehman FB; Blessing JA; Delgado G; Louka M
    Cancer Treat Rep; 1983; 67(7-8):737-8. PubMed ID: 6871892
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase II clinical study of tamoxifen in advanced endometrial adenocarcinoma: a Gynecologic Oncology Group study.
    Slavik M; Petty WM; Blessing JA; Creasman WT; Homesley HD
    Cancer Treat Rep; 1984 May; 68(5):809-11. PubMed ID: 6722836
    [No Abstract]   [Full Text] [Related]  

  • 14. [Advanced gastric cancer successfully resected following cisplatin therapy. A case report].
    Kishimoto Y; Saji S; Ishikawa T; Takahashi H; Kawata R; Tanemura H; Furuta T; Ohashi H; Sakata K; Shimokawa K
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):139-42. PubMed ID: 3942395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of advanced endometrial adenocarcinoma with tamoxifen.
    Swenerton KD
    Cancer Treat Rep; 1980; 64(6-7):805-11. PubMed ID: 7427965
    [No Abstract]   [Full Text] [Related]  

  • 16. cis-Dichlorodiammineplatinum(II) for the treatment of advanced ovarian cancer.
    Young RC; Von Hoff DD; Gormley P; Makuch R; Cassidy J; Howser D; Bull JM
    Cancer Treat Rep; 1979; 63(9-10):1539-44. PubMed ID: 387224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of cisplatin, doxorubicin, and cyclophosphamide to treat advanced and recurrent adenocarcinoma of the endometrium.
    Hancock KC; Freedman RS; Edwards CL; Rutledge FN
    Cancer Treat Rep; 1986 Jun; 70(6):789-91. PubMed ID: 3731140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination chemotherapy for advanced endometrial adenocarcinoma.
    Deppe G; Bruckner HW; Cohen CJ
    Int J Gynaecol Obstet; 1980; 18(3):168-9. PubMed ID: 6109646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medrogestone therapy in advanced endometrial adenocarcinoma.
    Waterman EA; Benson RC
    Obstet Gynecol; 1967 Nov; 30(5):626-34. PubMed ID: 4167865
    [No Abstract]   [Full Text] [Related]  

  • 20. [A case of recurrent endometrial cancer (clear cell adenocarcinoma) remarkably responsive to combination chemotherapy containing cisplatin].
    Kitayama S; Iwahashi M; Iwahashi M; Yamoto M; Nakano R
    Gan To Kagaku Ryoho; 1989 May; 16(5):2099-101. PubMed ID: 2730095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.